ABI
ZBH icon

Adamant Biomedical Investments’s Zimmer Biomet ZBH Stock Holding History

Adamant Biomedical Investments’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2.84M Hold
25,750
– – 0.68% 52
2014
Q3 		$2.51M Buy
+25,750
New +$2.53M 0.63% 52

Other funds holding ZBH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adamant Biomedical Investments's ZBH Position: Q4 2014 in Review

Adamant Biomedical Investments held its Zimmer Biomet (ZBH) position steady in Q4 2014 at 25,750 shares worth $2.84M. The position accounts for 0.68% of the portfolio, ranked #52.

Adamant Biomedical Investments first reported a position in ZBH in Q3 2014 and has held it in 2 quarters since. 750 funds tracked by Wall St. Rank hold ZBH as of Q4 2014.

  • Adamant Biomedical Investments held 25,750 shares of Zimmer Biomet worth $2.84M as of Q4 2014.
  • Adamant Biomedical Investments left its Zimmer Biomet share count unchanged in Q4 2014.
  • Zimmer Biomet made up 0.68% of Adamant Biomedical Investments's portfolio in Q4 2014, its #52 holding.
  • Adamant Biomedical Investments first reported a position in Zimmer Biomet in Q3 2014 and has held it in 2 quarters since.
  • 750 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.